Status:
COMPLETED
Respiratory Drive in Patients With Univentricular Congenital Heart Disease
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Univentricular Heart
Children, Adult
Eligibility:
All Genders
8+ years
Phase:
NA
Brief Summary
The aim is to evaluate the correlation between the respiratory control to hypercapnia at rest and the VE/VCO2 slope measured during cardiopulmonary exercise testing. The hypothesis is that patient wi...
Detailed Description
The patients with univentricular congenital heart disease will perform : * a cardiopulmonary exercise testing with measure VE/VCO2 slope, * a measure of the respiratory drive to hypercapnia with occl...
Eligibility Criteria
Inclusion
- Functionally univentricular congenital heart disease
- Age ≥ 8 years
- Consent of the adult patient or the parents or legal guardians of the minor patient.
- Beneficiary of the social security scheme
Exclusion
- Size \<120 cm (minimum size for the stress test)
- Medical contraindication to exercise test or presence of : myocardial infarction less than 3 months old, unstable angina, uncontrolled severe arrhythmias, symptomatic aortic stenosis, uncontrolled heart failure, pulmonary embolism, evolutionary phlebitis, pericarditis, myocarditis, progressive endocarditis, aortic dissection
- Unstable patient with severe intellectual disability or complex pathology making polysomnography impossible
- Pregnant woman
Key Trial Info
Start Date :
October 16 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 7 2021
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT03818373
Start Date
October 16 2017
End Date
July 7 2021
Last Update
January 4 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Arnaud de Villeneuve - University Hospital Pediatric and Congenital Cardiology Department Regional Reference Center - M3C
Montpellier, Occitanie, France, 34295
2
Institut Saint-Pierre
Palavas-les-Flots, France